{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:46:19Z","timestamp":1789238779733,"version":"build-2803163510"},"reference-count":289,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92359202"],"award-info":[{"award-number":["92359202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3405500"],"award-info":[{"award-number":["2024YFC3405500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbcan.2025.189324","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:06:59Z","timestamp":1745060819000},"page":"189324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The duality of GSK-3\u03b2 in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways"],"prefix":"10.1016","volume":"1880","author":[{"given":"Zufa","family":"Sabeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.bbcan.2025.189324_bb0005","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u2014a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur. Urol."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189324_bb0020","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT-related gene signature for the prognosis of human bladder cancer","volume":"24","author":"Cao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0030","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189324_bb0035","doi-asserted-by":"crossref","first-page":"13949","DOI":"10.1111\/jcmm.16003","article-title":"IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer","volume":"24","author":"Huang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189324_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.010","article-title":"Lymphatic metastasis of bladder cancer: molecular mechanisms, diagnosis and targeted therapy","volume":"505","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/molecules27030731","article-title":"Advances in management of bladder cancer&mdash;the role of photodynamic therapy","volume":"27","author":"Kubrak","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.currproblcancer.2014.06.001","article-title":"Multimodal management of muscle-invasive bladder cancer","volume":"38","author":"Park","year":"2014","journal-title":"Curr. Probl. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10353","article-title":"(Nano) platforms in bladder cancer therapy: challenges and opportunities","volume":"8","author":"Ashrafizadeh","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189324_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127375","article-title":"A review of glycogen synthase Kinase-3 (GSK3) inhibitors for cancers therapies","volume":"253","author":"Thapa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0065","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"New horizons in bladder cancer research","author":"Boormans","year":"2020"},{"key":"10.1016\/j.bbcan.2025.189324_bb0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43024","article-title":"Epigenetic regulation of mammalian hedgehog signaling to the stroma determines the molecular subtype of bladder cancer","volume":"8","author":"Kim","year":"2019","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0075","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","article-title":"External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","volume":"23","author":"Chen","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/cancers11050686","article-title":"Integrative metabolomic and transcriptomic analysis for the study of bladder cancer","volume":"11","author":"Loras","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189324_bb0085","series-title":"Urothelial Carcinoma: Methods and Protocols","first-page":"335","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in bladder cancer","author":"Sathe","year":"2018"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0090","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.3390\/ijms25063105","article-title":"Strategies for overcoming immune evasion in bladder cancer","volume":"25","author":"Shin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb0095","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.3390\/ijms23084173","article-title":"Metabolomic approaches for detection and identification of biomarkers and altered pathways in bladder cancer","volume":"23","author":"di Meo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb0100","article-title":"Role of immunotherapy in bladder cancer","volume":"26","author":"Rhea","year":"2021","journal-title":"Cancer Treatm. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-022-01352-x","article-title":"Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells","volume":"15","author":"Shaw","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118659","article-title":"GSK-3\u03b2 in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer","volume":"1867","author":"Lin","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189324_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: functional insights from cell biology and animal models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0120","doi-asserted-by":"crossref","first-page":"4629495","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","volume":"2017","author":"Mancinelli","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbcan.2025.189324_bb0125","first-page":"6","article-title":"Recent advances in understanding the cellular roles of GSK-3","author":"Cormier","year":"2017","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","article-title":"Cell biology of canonical Wnt signaling","volume":"37","author":"Albrecht","year":"2021","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/cells9061427","article-title":"The role of GSK-3 in Cancer immunotherapy: GSK-3 inhibitors as a new frontier in cancer treatment","volume":"9","author":"Augello","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0145","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0150","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation","volume":"7","author":"Frame","year":"2001","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb0155","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/15384047.2019.1595283","article-title":"Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses","volume":"20","author":"Sahin","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118743","article-title":"GSK-3 in liver diseases: friend or foe?","volume":"1867","author":"Emma","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) Mol. Cell Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0165","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/cas.13028","article-title":"Glycogen synthase kinase-3\u03b2 is a pivotal mediator of cancer invasion and resistance to therapy","volume":"107","author":"Domoto","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100532","article-title":"Glycogen synthase kinase-3\u03b2 inhibitors as a novel promising target in the treatment of cancer: medicinal chemistry perspective","volume":"4","author":"Karati","year":"2022","journal-title":"Results Chem."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb0175","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: revisiting glycogen synthase kinase-3\u03b2 as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0180","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41598-025-85868-5","article-title":"Exploring novel and potent glycogen synthase kinase-3\u03b2 inhibitors through systematic drug designing approach","volume":"15","author":"Ganai","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0185","doi-asserted-by":"crossref","first-page":"19977","DOI":"10.1038\/s41598-019-56461-4","article-title":"9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer","volume":"9","author":"Kuroki","year":"2019","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189324_bb0190","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/1078-0432.CCR-06-0196","article-title":"Aberrant nuclear accumulation of glycogen synthase kinase-3\u03b2 in human pancreatic cancer: association with kinase activity and tumor dedifferentiation","volume":"12","author":"Ougolkov","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0195","first-page":"735","article-title":"Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor \u03baB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells","volume":"110","author":"Ougolkov","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0200","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.bjc.6605437","article-title":"Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma","volume":"101","author":"Bilim","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.bbcan.2025.189324_bb0205","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-10-0275","article-title":"Glycogen synthase kinase-3\u03b2: a prognostic marker and a potential therapeutic target in human bladder cancer","volume":"16","author":"Naito","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0210","article-title":"Target inhibition on GSK-3\u03b2 by miR-9 to modulate proliferation and apoptosis of bladder cancer cells","volume":"22","author":"Dong","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0215","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.3390\/curroncol30060406","article-title":"Targeting pro-survival autophagy enhanced GSK-3&beta; inhibition-induced apoptosis and retarded proliferation in bladder cancer cells","volume":"30","author":"Shirono","year":"2023","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13577-024-01053-2","article-title":"The mechanism of the contribution of ICAM-1 to epithelial\u2013mesenchymal transition (EMT) in bladder cancer","volume":"37","author":"Zarzycka","year":"2024","journal-title":"Hum. Cell"},{"issue":"23","key":"10.1016\/j.bbcan.2025.189324_bb0225","doi-asserted-by":"crossref","first-page":"16989","DOI":"10.1074\/jbc.M700610200","article-title":"Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis","volume":"282","author":"Meares","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.46439\/cancerbiology.5.058","article-title":"The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy","volume":"5","author":"Crespo","year":"2024","journal-title":"J Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0235","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/22221751.2022.2026198","article-title":"Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt\/\u03b2-catenin\/TCF1 axis in CD4+ T cells","volume":"11","author":"Wen","year":"2022","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118626","article-title":"GSK-3: An important kinase in colon and pancreatic cancers","volume":"1867","author":"Vidri","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189324_bb0245","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3389\/fimmu.2018.02527","article-title":"Polydatin prevents lipopolysaccharide (LPS)-induced Parkinson\u2019s disease via regulation of the AKT\/GSK3\u03b2-Nrf2\/NF-\u03baB signaling axis","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109886","article-title":"Wnt signalling pathway in bladder cancer","volume":"79","author":"Wu","year":"2021","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/096504017X14902261600566","article-title":"MicroRNA-940 targets INPP4A or GSK3\u03b2 and activates the Wnt\/\u03b2-catenin pathway to regulate the malignant behavior of bladder cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Oncol. Res."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189324_bb0260","article-title":"MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3\u03b2\/\u03b2-catenin pathway","volume":"23","author":"Dong","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.239","article-title":"Effects of microRNA-135a on the epithelial\u2013mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3\u03b2 through the Wnt\/\u03b2-catenin signaling pathway","volume":"50","author":"Mao","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189324_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.03.025","article-title":"Regulation of nuclear factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis?","volume":"509","author":"Mirzaei","year":"2021","journal-title":"Cancer Lett."},{"issue":"6791","key":"10.1016\/j.bbcan.2025.189324_bb0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189324_bb0280","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16635","article-title":"New insights into the role of GSK-3\u03b2 in the brain: from neurodegenerative disease to tumorigenesis","volume":"11","author":"Lai","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bbcan.2025.189324_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116377","article-title":"Glycogen synthase kinase-3: a potential immunotherapeutic target in tumor microenvironment","volume":"173","author":"Liang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb0290","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb0295","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/cam4.1641","article-title":"Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration","volume":"7","author":"Zhao","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2025.189324_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1010-z","article-title":"The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt\/\u03b2-catenin signaling pathway","volume":"19","author":"Guo","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0305","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3892\/or.2017.5959","article-title":"Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells","volume":"38","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13880209.2019.1626449","article-title":"Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt\/\u0392-catenin pathway","volume":"57","author":"Gong","year":"2019","journal-title":"Pharm. Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0315","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.7150\/ijbs.35541","article-title":"EFEMP2 suppresses epithelial-mesenchymal transition via Wnt\/\u03b2-catenin signaling pathway in human bladder cancer","volume":"15","author":"Zhou","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0320","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.21037\/tau-20-1293","article-title":"LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt\/\u03b2-catenin and JAK2\/STAT3 signaling pathways","volume":"9","author":"Huang","year":"2020","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0325","series-title":"Long Non-Coding RNA CASC9 Promotes Bladder Cancer Tumorigenicity and Metastasis Via Modulating FZD6\/Wnt\/\u03b2-Catenin Signaling Pathway","author":"Zhan","year":"2020"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-018-1263-9","article-title":"CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt\/\u03b2-catenin signaling via transactivation of GSK-3\u03b2 and Axin2 expression","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-018-0359-6","article-title":"DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt\/\u03b2-catenin pathway via GSK3\u03b2","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0340","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/emboj.2012.146","article-title":"Three decades of Wnts: a personal perspective on how a scientific field developed","volume":"31","author":"Nusse","year":"2012","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0345","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5264","key":"10.1016\/j.bbcan.2025.189324_bb0350","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3\u03b2 to the APC-\u03b2-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0355","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.devcel.2019.01.025","article-title":"Wnt\/Beta-catenin signaling regulation and a role for biomolecular condensates","volume":"48","author":"Schaefer","year":"2019","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0360","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/cells9051110","article-title":"Targeting GSK3 and associated signaling pathways involved in cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0365","first-page":"145","article-title":"MicroRNA-940 Targets INPP4A or GSK3&#946; and activates the Wnt\/&#946;-catenin pathway to regulate the malignant behavior of bladder cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Therap."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0370","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1007\/s13277-016-5460-9","article-title":"MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3\u03b2 and activating Wnt signaling in bladder cancer cells","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0375","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/carcin\/bgac087","article-title":"LncRNA GAS5 regulates the Wnt\/\u03b2-catenin pathway through the miR-18a-5p\/AXIN2\/GSK3\u03b2 axis to inhibit the proliferation and migration of bladder cancer cells","volume":"43","author":"Zhang","year":"2022","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189324_bb0380","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/molecules24162881","article-title":"Involvement of mitochondrial dysfunction, endoplasmic reticulum stress, and the PI3K\/AKT\/mTOR pathway in Nobiletin-induced apoptosis of human bladder cancer cells","volume":"24","author":"Goan","year":"2019","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0385","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/ijms21061905","article-title":"Natural products targeting ER stress, and the functional Link to mitochondria","volume":"21","author":"Martucciello","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb0390","series-title":"CB-5083 and Luteolin Synergistically Induce Apoptosis of Bladder cancer Cells Via Multiple Mechanisms","author":"Sun","year":"2023"},{"key":"10.1016\/j.bbcan.2025.189324_bb0395","article-title":"Endoplasmic reticulum stress and tumor microenvironment in bladder cancer: the missing link","volume":"9","author":"Nie","year":"2021","journal-title":"Front. Cell Developm. Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbi.2018.06.013","article-title":"Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway","volume":"292","author":"Zhang","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168351","article-title":"High expression of Derlin-1 is associated with the malignancy of bladder cancer in a Chinese Han population","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nsmb.2793","article-title":"Cleaning up in the endoplasmic reticulum: ubiquitin in charge","volume":"21","author":"Christianson","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ncb2882","article-title":"Der1 promotes movement of misfolded proteins through the endoplasmic reticulum membrane","volume":"16","author":"Mehnert","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0420","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15001","article-title":"Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K\/AKT and ERK\/MMP signaling","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0425","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/md17050287","article-title":"Flaccidoxide-13-acetate-induced apoptosis in human bladder cancer cells is through activation of p38\/JNK, mitochondrial dysfunction, and endoplasmic reticulum stress regulated pathway","volume":"17","author":"Wu","year":"2019","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0430","article-title":"Licochalcone A-induced human bladder cancer T24 cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress","volume":"2013","author":"Yuan","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"161","key":"10.1016\/j.bbcan.2025.189324_bb0435","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001731","article-title":"ER stress inhibits mTORC2 and Akt signaling through GSK-3\u03b2\u2013mediated phosphorylation of Rictor","volume":"4","author":"Chen","year":"2011","journal-title":"Sci. Signal."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0440","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1089\/neu.2018.5966","article-title":"Loureirin B promotes axon regeneration by inhibiting endoplasmic reticulum stress: induced mitochondrial dysfunction and regulating the Akt\/GSK-3\u03b2 pathway after spinal cord injury","volume":"36","author":"Wang","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/ATVBAHA.111.237941","article-title":"Endoplasmic reticulum stress and glycogen synthase kinase-3\u03b2 activation in apolipoprotein E\u2013deficient mouse models of accelerated atherosclerosis","volume":"32","author":"McAlpine","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0450","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.biopha.2017.03.028","article-title":"TMF protects chondrocytes from ER stress-induced apoptosis by down-regulating GSK-3\u03b2","volume":"89","author":"Yuan","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0455","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189324_bb0460","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/0008-5472.CAN-22-3032","article-title":"The mTOR signaling pathway interacts with the ER stress response and the unfolded protein response in cancer","volume":"83","author":"Mafi","year":"2023","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0465","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1089\/ars.2009.2501","article-title":"Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species","volume":"11","author":"Shimizu","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0470","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA) Mol. Cell Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0475","first-page":"9117","article-title":"Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfn266","article-title":"Cadmium toxicity toward autophagy through ROS-activated GSK-3\u03b2 in mesangial cells","volume":"108","author":"Wang","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb0485","first-page":"2014","article-title":"Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS\/GSK-3\u03b2\/NF-\u03baB signaling pathway","author":"Li","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbcan.2025.189324_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115166","article-title":"High-throughput screening identifies stevioside as a potent agent to induce apoptosis in bladder cancer cells","volume":"203","author":"Chen","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0495","doi-asserted-by":"crossref","first-page":"15903","DOI":"10.1038\/s41598-023-42994-2","article-title":"NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy","volume":"13","author":"Al Shboul","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0500","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/jcmm.13626","article-title":"Endoplasmic reticulum stress induces spatial memory deficits by activating GSK-3","volume":"22","author":"Lin","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0505","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/jpet.108.148122","article-title":"Glycogen synthase kinase-3\u03b2 mediates endoplasmic reticulum stress-induced lysosomal apoptosis in leukemia","volume":"329","author":"Huang","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0510","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cancers11050631","article-title":"Emerging roles of the endoplasmic reticulum associated unfolded protein response in cancer cell migration and invasion","volume":"11","author":"Limia","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb0515","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/ijms20112654","article-title":"Impact and relevance of the unfolded protein response in HNSCC","volume":"20","author":"Pluquet","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0520","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/ar.23590","article-title":"TLR4 promotes breast cancer metastasis via Akt\/GSK3\u03b2\/\u03b2-catenin pathway upon LPS stimulation","volume":"300","author":"Li","year":"2017","journal-title":"Anat. Rec."},{"key":"10.1016\/j.bbcan.2025.189324_bb0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2019.04.026","article-title":"p21-activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3\u03b2-\u03b2-catenin signaling pathway in pancreatic cancer cells","volume":"456","author":"Wu","year":"2019","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0530","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.26102","article-title":"\u0392-Catenin as a potential key target for tumor suppression","volume":"129","author":"Fu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189324_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109366","article-title":"Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"337","author":"Xie","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbcan.2025.189324_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-29-160","article-title":"Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells","volume":"29","author":"Shahjee","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0545","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/kjm2.12194","article-title":"Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K\/AKT signaling","volume":"36","author":"Tao","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0550","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbrc.2015.05.117","article-title":"TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis","volume":"463","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb0555","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.7150\/jca.95549","article-title":"ACAT1 promotes proliferation and metastasis of bladder cancer via AKT\/GSK3\u03b2\/c-Myc signaling pathway","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189324_bb0560","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2017.08.009","article-title":"Silencing of Glut1 induces chemoresistance via modulation of Akt\/GSK-3\u03b2\/\u03b2-catenin\/survivin signaling pathway in breast cancer cells","volume":"636","author":"Oh","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0565","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jnc.14899","article-title":"Synergistic growth inhibition mediated by dual PI3K\/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models","volume":"153","author":"Von Achenbach","year":"2020","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0570","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.98","article-title":"Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation","volume":"7","author":"Zhao","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbcan.2025.189324_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.10.022","article-title":"Editor PI3K\/Akt signaling in human cancer","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0580","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1073\/pnas.1501441112","article-title":"HDAC inhibition prevents white matter injury by modulating microglia\/macrophage polarization through the GSK3\u03b2\/PTEN\/Akt axis","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0585","first-page":"329","article-title":"PI3K\/AKT pathway genetic alterations and dysregulation of expression in bladder cancer","volume":"24","author":"Kachrilas","year":"2019","journal-title":"J. BUON"},{"key":"10.1016\/j.bbcan.2025.189324_bb0590","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0595","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3892\/ijo.2014.2505","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells","volume":"45","author":"Moon","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0600","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12032-025-02613-8","article-title":"Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment","volume":"42","author":"Abulsoud","year":"2025","journal-title":"Med. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0605","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.cellsig.2014.08.021","article-title":"Angiogenin interacts with ribonuclease inhibitor regulating PI3K\/AKT\/mTOR signaling pathway in bladder cancer cells","volume":"26","author":"Peng","year":"2014","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0610","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.18632\/oncotarget.1706","article-title":"Antitumor activity of the combination of an HSP90 inhibitor and a PI3K\/mTOR dual inhibitor against cholangiocarcinoma","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb0615","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.18632\/oncotarget.3502","article-title":"Targeting Hsp90 in urothelial carcinoma","volume":"6","author":"Chehab","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0620","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3349\/ymj.2020.61.7.587","article-title":"Synergistic antitumor effects of combined treatment with HSP90 inhibitor and PI3K\/mTOR dual inhibitor in cisplatin-resistant human bladder cancer cells","volume":"61","author":"Kim","year":"2020","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0625","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7150\/jca.31422","article-title":"Cryptotanshinone Inhibites bladder cancer cell proliferation and promotes apoptosis via the PTEN\/PI3K\/AKT pathway","volume":"11","author":"Liu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189324_bb0630","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11064-016-2044-4","article-title":"AKT\/GSK3\u03b2 signaling in glioblastoma","volume":"42","author":"Majewska","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0635","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jcp.22123","article-title":"LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3\u03b2-inactivation mechanism","volume":"224","author":"Zhang","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0640","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/antiox8090327","article-title":"Induction of G2\/M cell cycle arrest and apoptosis by genistein in human bladder cancer T24 cells through inhibition of the ROS-dependent PI3k\/Akt signal transduction pathway","volume":"8","author":"Park","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbcan.2025.189324_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109246","article-title":"PP9, a steroidal saponin, induces G2\/M arrest and apoptosis in human colorectal cancer cells by inhibiting the PI3K\/Akt\/GSK3\u03b2 pathway","volume":"331","author":"Yao","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0650","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-04-3642","article-title":"Glycogen synthase kinase-3\u03b2 participates in nuclear factor \u03baB\u2013mediated gene transcription and cell survival in pancreatic cancer cells","volume":"65","author":"Ougolkov","year":"2005","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.bbcan.2025.189324_bb0655","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.2174\/1381612825666191112142943","article-title":"Wnt-\u03b2-catenin signaling pathway, the achilles\u2019 heels of cancer multidrug resistance","volume":"25","author":"Ghandadi","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0660","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181711","article-title":"Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0665","doi-asserted-by":"crossref","first-page":"38553","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189324_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2022.108225","article-title":"Dual therapeutic approach to modulate glycogen synthase kinase \u22123 beta (GSK-3\u0392) and inhibitor of nuclear factor kappa kinase-beta (IKK-\u03b2) receptors by in silico designing of inhibitors","volume":"115","author":"Roy Acharyya","year":"2022","journal-title":"J. Mol. Graph. Model."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0675","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-\u03baB: the enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0680","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3892\/mmr.2013.1364","article-title":"Ursolic acid induces apoptosis via Akt\/NF-\u03baB signaling suppression in T24 human bladder cancer cells","volume":"7","author":"Gai","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0685","first-page":"1271","article-title":"Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, BCL-xL, XIAP and survivin in bladder cancer cells","volume":"41","author":"Kunze","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0690","first-page":"26","article-title":"Bufalin induces G0\/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells","volume":"732","author":"Huang","year":"2012","journal-title":"Mutat. Res. Fundam. Mol. Mechan. Mutagenes."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0695","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3892\/ijo.2012.1511","article-title":"Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells","volume":"41","author":"Yu","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0700","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1097-2765(01)00380-X","article-title":"Blocking caspase-3-mediated proteolysis of IKK\u03b2 suppresses TNF-\u03b1-induced apoptosis","volume":"8","author":"Tang","year":"2001","journal-title":"Mol. Cell"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189324_bb0705","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.3390\/ijms22168841","article-title":"Inhibition of cell proliferation and metastasis by Scutellarein regulating PI3K\/Akt\/NF-\u03baB signaling through PTEN activation in hepatocellular carcinoma","volume":"22","author":"Ha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0710","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189324_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-019-2695-3","article-title":"Metabolome analysis reveals dermal histamine accumulation in murine dermatitis provoked by genetic deletion of P-glycoprotein and breast cancer resistance protein","volume":"36","author":"Hashimoto","year":"2019","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb0720","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/carcin\/bgt187","article-title":"Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial\u2013mesenchymal transition and activation of Akt\/GSK-3\u03b2\/Snail signaling","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0725","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/cas.14126","article-title":"Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial\u2013mesenchymal transition via Akt\/GSK3\u03b2 signaling","volume":"110","author":"Xiao","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb0730","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.2147\/OTT.S251830","article-title":"TP53INP2 modulates epithelial-to-mesenchymal transition via the GSK-3\u03b2\/\u03b2-catenin\/Snail1 pathway in bladder cancer cells","volume":"13","author":"Zhou","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0735","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.274","article-title":"C-met and CREB1 are involved in miR-433-mediated inhibition of the epithelial\u2013mesenchymal transition in bladder cancer by regulating Akt\/GSK-3\u03b2\/Snail signaling","volume":"7","author":"Xu","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189324_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120635","article-title":"Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor","volume":"269","author":"Allen","year":"2021","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0745","article-title":"GSK-3\u03b2 in pancreatic cancer: spotlight on 9-ING-41, its therapeutic potential and immune modulatory properties","volume":"10","author":"Park","year":"2021","journal-title":"Biol. Int."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb0750","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/0008-5472.CAN-17-0491","article-title":"Small-molecule inhibition of PD-1 transcription is an effective alternative to antibody blockade in cancer therapy","volume":"78","author":"Taylor","year":"2018","journal-title":"Cancer Res."},{"issue":"6332","key":"10.1016\/j.bbcan.2025.189324_bb0755","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aaf0683","article-title":"Rescue of exhausted CD8 T cells by PD-1\u2013targeted therapies is CD28-dependent","volume":"355","author":"Kamphorst","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0760","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1038\/ncomms11154","article-title":"Repression of GSK3 restores NK cell cytotoxicity in AML patients","volume":"7","author":"Parameswaran","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189324_bb0765","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fimmu.2017.01653","article-title":"Glycogen synthase kinase 3 inactivation compensates for the lack of CD28 in the priming of CD8+ cytotoxic T-cells: implications for anti-PD-1 immunotherapy","volume":"8","author":"Taylor","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0770","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of co-receptor PD-1 to enhance CD8+ cytolytic T cell responses","volume":"44","author":"Taylor","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0775","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jmg.2006.046185","article-title":"The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus","volume":"44","author":"Hellquist","year":"2007","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0780","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-018-02897-7","article-title":"Gimap5-dependent inactivation of GSK3\u03b2 is required for CD4+ T cell homeostasis and prevention of immune pathology","volume":"9","author":"Patterson","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urolonc.2016.10.004","article-title":"A review of the PD-1\/PD-L1 checkpoint in bladder cancer: from mediator of immune escape to target for treatment11MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose","volume":"35","author":"Zhou","year":"2017","journal-title":"Urologic Oncol. Semin. Origin. Investig."},{"issue":"10031","key":"10.1016\/j.bbcan.2025.189324_bb0790","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189324_bb0795","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1158\/1078-0432.CCR-08-0731","article-title":"T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival","volume":"14","author":"Boorjian","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb0800","first-page":"87","article-title":"Expression of tumoral GSK3-\u03b2, PD-L1, and CD8 cell density in urothelial carcinomas, association with tumor grade and overall survival","volume":"12","author":"Almeida Rodrigues","year":"2023","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0805","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.2147\/COPD.S327887","article-title":"GSK-3\u03b2 inhibitors attenuate the PM2. 5-induced inflammatory response in bronchial epithelial cells","author":"Zou","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0810","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nchembio.1690","article-title":"GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors","volume":"11","author":"Thorne","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0815","doi-asserted-by":"crossref","first-page":"1360436","DOI":"10.3389\/fimmu.2024.1360436","article-title":"Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3\u03b2 inhibitor enhances antitumor immune response against bladder cancer","volume":"15","author":"Yoon","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0820","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/biology10070610","article-title":"GSK-3? In pancreatic Cancer: spotlight on 9-ING-41, its therapeutic potential and immune modulatory properties","volume":"10","author":"Park","year":"2021","journal-title":"Biology"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189324_bb0825","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-17-0799","article-title":"GSK3 inhibition drives maturation of NK cells and enhances their antitumor activity","volume":"77","author":"Cichocki","year":"2017","journal-title":"Cancer Res."},{"issue":"6332","key":"10.1016\/j.bbcan.2025.189324_bb0830","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1\u2013mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0835","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1412900","article-title":"Modulation of CD8+ memory stem T cell activity and glycogen synthase kinase 3\u03b2 inhibition enhances anti-tumoral immunity in gastric cancer","volume":"7","author":"Zhang","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102555","article-title":"Non-redundant activity of GSK-3&#x3b1; and GSK-3&#x3b2; in T&#xa0;cell-mediated tumor rejection","volume":"24","author":"Steele","year":"2021","journal-title":"iScience"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189324_bb0845","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.3390\/ijms241310870","article-title":"GSK-3 inhibitor Elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer","volume":"24","author":"Huntington","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0850","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.bbcan.2025.189324_bb0860","doi-asserted-by":"crossref","first-page":"34217","DOI":"10.18632\/oncotarget.9079","article-title":"Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: a systemic review and meta-analysis","volume":"7","author":"Mei","year":"2016","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.bbcan.2025.189324_bb0865","doi-asserted-by":"crossref","first-page":"40451","DOI":"10.18632\/oncotarget.9625","article-title":"Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.bbcan.2025.189324_bb0870","doi-asserted-by":"crossref","first-page":"39916","DOI":"10.18632\/oncotarget.9537","article-title":"Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Gu\u00e9rin therapy in bladder cancer","volume":"7","author":"Pichler","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133552","article-title":"Tumor-associated macrophages provide significant prognostic information in urothelial bladder cancer","volume":"10","author":"Bostr\u00f6m","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bbcan.2025.189324_bb0880","doi-asserted-by":"crossref","first-page":"20204","DOI":"10.18632\/oncotarget.3887","article-title":"High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"38","key":"10.1016\/j.bbcan.2025.189324_bb0885","doi-asserted-by":"crossref","first-page":"25294","DOI":"10.18632\/oncotarget.25334","article-title":"Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0890","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003446","article-title":"Inhibition of glycogen synthase kinase 3\u03b2 alleviates chronic renal allograft dysfunction in rats","volume":"105","author":"Deng","year":"2021","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb0895","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/cns.13715","article-title":"Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia\/macrophages phenotype polarization through GSK-3\u03b2\/Nrf2 pathway","volume":"27","author":"Cai","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0900","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/liv.15094","article-title":"Aurora kinase A regulates liver regeneration through macrophages polarization and Wnt\/\u03b2-catenin signalling","volume":"42","author":"Yin","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.bbcan.2025.189324_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120032","article-title":"Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism","volume":"297","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb0910","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/ATVBAHA.118.311363","article-title":"Inhibiting glycogen synthase kinase 3 reverses obesity-induced white adipose tissue inflammation by regulating apoptosis inhibitor of macrophage\/CD5L-mediated macrophage migration","volume":"38","author":"Wang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb0915","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2013.04.022","article-title":"Activator or inhibitor? GSK-3 as a new drug target","volume":"86","author":"Takahashi-Yanaga","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189324_bb0920","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jbior.2013.09.013","article-title":"Diverse roles of GSK-3: tumor promoter\u2013tumor suppressor, target in cancer therapy","volume":"54","author":"McCubrey","year":"2014","journal-title":"Adv. Biol. Regul."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb0925","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/1541-7786.MCR-13-0332-T","article-title":"Activation of the Wnt pathway through AR79, a GSK3\u03b2 inhibitor, promotes prostate cancer growth in soft tissue and bone","volume":"11","author":"Jiang","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0930","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2008.06.032","article-title":"Glycogen synthase kinase 3\u03b2 induces apoptosis in cancer cells through increase of survivin nuclear localization","volume":"272","author":"Li","year":"2008","journal-title":"Cancer Lett."},{"issue":"27","key":"10.1016\/j.bbcan.2025.189324_bb0935","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/onc.2014.279","article-title":"Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis","volume":"34","author":"Dembowy","year":"2015","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189324_bb0940","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1158\/0008-5472.CAN-06-4665","article-title":"The role of glycogen synthase kinase 3\u03b2 in the transformation of epidermal cells","volume":"67","author":"Ma","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189324_bb0945","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 inhibitors: preclinical and clinical focus on CNS","volume":"4","author":"Eldar-Finkelman","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"9992","key":"10.1016\/j.bbcan.2025.189324_bb0950","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(14)61842-0","article-title":"Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data","volume":"386","author":"Shine","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0955","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"H\u00f6glinger","year":"2014","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0960","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3\u03b2 in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb0965","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0970","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","article-title":"Treatment of Alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: a pilot study","volume":"33","author":"Del Ser","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb0975","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb0980","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbcan.2025.189324_bb0985","series-title":"Targeting GSK-3: A Promising Approach for cancer Therapy?","author":"Ougolkov","year":"2006"},{"issue":"17","key":"10.1016\/j.bbcan.2025.189324_bb0990","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2174\/1568026620666200516153136","article-title":"Glycogen synthase kinase 3 (GSK3): its role and inhibitors","volume":"20","author":"Wadhwa","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"29","key":"10.1016\/j.bbcan.2025.189324_bb0995","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.2174\/1381612823666170714141450","article-title":"GSK3 inhibitors in the therapeutic development of diabetes, cancer and neurodegeneration: past, present and future","volume":"23","author":"Maqbool","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbcan.2025.189324_bb1000","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.3233\/JAD-179934","article-title":"The conundrum of GSK3 inhibitors: is it the Dawn of a new beginning?","volume":"64","author":"Bhat","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/00220345211020652","article-title":"GSK3 inhibitor-induced Dentinogenesis using a hydrogel","volume":"101","author":"Alaohali","year":"2022","journal-title":"J. Dent. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb1010","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.3390\/curroncol30060406","article-title":"Targeting pro-survival autophagy enhanced GSK-3\u03b2 inhibition-induced apoptosis and retarded proliferation in bladder cancer cells","volume":"30","author":"Shirono","year":"2023","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb1015","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1158\/2767-9764.CRC-24-0408","article-title":"Elraglusib induces cytotoxicity via direct microtubule destabilization independently of GSK3 inhibition","volume":"4","author":"Coats","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189324_bb1020","doi-asserted-by":"crossref","first-page":"viii9","DOI":"10.1093\/annonc\/mdy268.030","article-title":"9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers","volume":"29","author":"Kuroki","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10637-015-0310-y","article-title":"LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models","volume":"34","author":"Barnard","year":"2016","journal-title":"Investig. New Drugs"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb1030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/CAD.0000000000000278","article-title":"Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors","volume":"26","author":"Doi","year":"2015","journal-title":"Anti-Cancer Drugs"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb1035","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189324_bb1040","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1158\/0008-5472.CAN-12-4358","article-title":"Indirubin derivative 6BIO suppresses metastasis","volume":"73","author":"Braig","year":"2013","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189324_bb1045","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31335","article-title":"Glycogen synthase kinase-3\u03b2: a multifaceted player in ischemia-reperfusion injury and its therapeutic prospects","volume":"239","author":"Li","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fnmol.2017.00391","article-title":"Differential roles of glycogen synthase kinase 3 subtypes alpha and beta in cortical development","volume":"10","author":"Ma","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb1055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/13543776.2020.1815706","article-title":"Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016\u20132019)","volume":"30","author":"Roca","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb1060","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.3390\/ijms24087541","article-title":"GSK-3\u03b2 allosteric inhibition: a dead end or a new pharmacological frontier?","volume":"24","author":"Balboni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2006.05.2076","article-title":"P4\u2013335: glycogen synthase kinase\u20133\u03b2 inhibitors from marine origin","volume":"2","author":"Alonso","year":"2006","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbcan.2025.189324_bb1070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2012.12.014","article-title":"Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin","volume":"60","author":"Bidon-Chanal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb1075","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/np0601399","article-title":"Manzamine B and E and ircinal a related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer\u2019s diseases","volume":"69","author":"Rao","year":"2006","journal-title":"J. Nat. Prod."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189324_bb1080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/md16080252","article-title":"Manzamine A exerts anticancer activity against human colorectal cancer cells","volume":"16","author":"Lin","year":"2018","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb1085","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3\u03b2 by tideglusib","volume":"287","author":"Dom\u00ednguez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb1090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jagp.2015.11.004","article-title":"Lithium use in older adults is associated with increased prescribing of parkinson medications","volume":"24","author":"Marras","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbcan.2025.189324_bb1095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2015.06.018","article-title":"The combination of lithium and l-Dopa\/carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: relevance for Parkinson\u2019 s disease therapy","volume":"1622","author":"Lazzara","year":"2015","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/antiox10010138","article-title":"Microdose lithium protects against pancreatic islet destruction and renal impairment in streptozotocin-elicited diabetes","volume":"10","author":"Zhang","year":"2021","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb1105","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/acs.jmedchem.7b00395","article-title":"Subtly modulating glycogen synthase kinase 3 \u03b2: allosteric inhibitor development and their potential for the treatment of chronic diseases","volume":"60","author":"Palomo","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189324_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114301","article-title":"Development of inhibitors targeting glycogen synthase kinase-3\u03b2 for human diseases: strategies to improve selectivity","volume":"236","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb1115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/adt.2008.164","article-title":"The current status of drug discovery against the human kinome","volume":"7","author":"Eglen","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2019.04.036","article-title":"Small molecule PROTACs in targeted therapy: an emerging strategy to induce protein degradation","volume":"174","author":"Xi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189324_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112949","article-title":"PROTACs suppression of GSK-3\u03b2, a crucial kinase in neurodegenerative diseases","volume":"210","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb1135","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.apsb.2020.01.003","article-title":"Small-molecule MDM2\/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives","volume":"10","author":"Fang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cbf.3369","article-title":"The PROTAC technology in drug development","volume":"37","author":"Zou","year":"2019","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbcan.2025.189324_bb1145","article-title":"Natural bioactive compounds form herbal medicine in Alzheimer\u2019s disease: from the perspective of GSK-3\u03b2","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb1150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/IGC.0b013e31827cfecb","article-title":"Lithium chloride and inhibition of glycogen synthase kinase 3\u03b2 as a potential therapy for serous ovarian cancer","volume":"23","author":"Novetsky","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"08","key":"10.1016\/j.bbcan.2025.189324_bb1155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0044-100186","article-title":"GSK-3 inhibitors: a double-edged sword?\u2013An update on tideglusib","volume":"68","author":"Mathuram","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.bbcan.2025.189324_bb1160","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin","volume":"33","author":"Gray","year":"2015","journal-title":"Investig. New Drugs"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189324_bb1165","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/1389450122666210204203950","article-title":"GSK-3 inhibitors in the regulation and control of colon carcinoma","volume":"22","author":"Nanda","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbcan.2025.189324_bb1170","series-title":"Pim Kinase Inhibitor Enhances FLT3 Inhibitor Gilteritinib Efficacy through GSK-3\u03b2 Activation and GSK-3\u03b2-Mediated c-Myc and Mcl-1 Proteasomal Degradation","author":"Lee","year":"2023"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12935-025-03676-3","article-title":"Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization","volume":"25","author":"Tan","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb1180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113413","article-title":"Mutant Kras as a biomarker plays a favorable role in FL118-induced apoptosis, reactive oxygen species (ROS) production and modulation of Survivin, Mcl-1 and XIAP in human bladder cancer","volume":"12","author":"Santha","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5603\/ep.95519","article-title":"Sh-Ambra1 inhibits IRS-1\/PI3K\/Akt signalling pathway to reduce autophagy in gestational diabetes","volume":"75","author":"Qu","year":"2024","journal-title":"Endokrynol. Pol."},{"issue":"40","key":"10.1016\/j.bbcan.2025.189324_bb1190","doi-asserted-by":"crossref","first-page":"34712","DOI":"10.1074\/jbc.M111.262766","article-title":"Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling*","volume":"286","author":"Iozzo","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.bbcan.2025.189324_bb1195","doi-asserted-by":"crossref","first-page":"30621","DOI":"10.1074\/jbc.M604633200","article-title":"Identification of novel glycogen synthase kinase-3\u03b2 substrate-interacting residues suggests a common mechanism for substrate recognition","volume":"281","author":"Ilouz","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb1200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5483\/BMBRep.2020.53.2.059","article-title":"Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1","volume":"53","author":"Zhuang","year":"2020","journal-title":"BMB Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb1205","first-page":"3842","article-title":"CREB1, a direct target of miR-122, promotes cell proliferation and invasion in bladder cancer","volume":"16","author":"Guo","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189324_bb1210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1338471","article-title":"Research on the signaling pathway and the related mechanism of traditional Chinese medicine intervention in chronic gastritis of the \u201cinflammation-cancer transformation\u201d","volume":"15","author":"Yan-Rui","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1215","series-title":"Characterization of cancer Stem Cells from Non-small Cell Lung Cancer","author":"Herreros","year":"2020"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189324_bb1220","doi-asserted-by":"crossref","first-page":"20634","DOI":"10.1002\/jcp.28669","article-title":"Inhibition of GLI2 with antisense-oligonucleotides: a potential therapy for the treatment of bladder cancer","volume":"234","author":"Raven","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189324_bb1225","doi-asserted-by":"crossref","first-page":"23330","DOI":"10.1074\/jbc.M201364200","article-title":"Expression and characterization of GSK-3 mutants and their effect on &#x3b2;-Catenin Phosphorylation in intact cells*","volume":"277","author":"Hagen","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"852","key":"10.1016\/j.bbcan.2025.189324_bb1230","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.ado0881","article-title":"Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3\u03b2","volume":"17","author":"Enos","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2025.189324_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107378","article-title":"Impact of GSK-3\u03b2 and CK-1\u03b4 on Wnt signaling pathway in alzheimer disease: a dual target approach","volume":"147","author":"Sharma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2025.189324_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154536","article-title":"PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt\/\u03b2-catenin signaling pathway","volume":"247","author":"Jiang","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189324_bb1245","first-page":"461","article-title":"Expression of cyclin D1 in urothelial carcinoma of urinary bladder and its association with tumour grade","volume":"33","author":"Nahar","year":"2024","journal-title":"Mymensingh Med. J."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb1250","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.7150\/ijbs.105072","article-title":"Inhibition of cyclin D1 by novel Biguanide derivative YB-004 increases the sensitivity of bladder cancer to Olaparib via causing G0 \/ G1 arrest","volume":"21","author":"Xiao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1255","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12672-024-01173-z","article-title":"The roles of FGFR3 and c-MYC in urothelial bladder cancer","volume":"15","author":"Bogale","year":"2024","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb1260","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.gendis.2021.03.002","article-title":"Calcineurin in development and disease","volume":"9","author":"Chen","year":"2022","journal-title":"Genes Diseas."},{"key":"10.1016\/j.bbcan.2025.189324_bb1265","series-title":"Molecular Characterization of the Differential Outcome of rai Modulation in Astrocytes and T Lymphocytes Leading to Context-Specific Cellular Dysfunction","author":"Montecchi","year":"2023"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb1270","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.18632\/aging.202982","article-title":"Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer","volume":"13","author":"Dai","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2025.189324_bb1275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/9789815223583124010017","article-title":"Role of epithelial-mesenchymal transition (EMT) therapy in personalized cancer treatment","author":"Ghosh","year":"2024","journal-title":"Precis. Med. Human Health"},{"key":"10.1016\/j.bbcan.2025.189324_bb1280","series-title":"Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression","article-title":"Silencing of KIF3B suppresses breast cancer progression by regulating EMT and Wnt\/B-Catenin signaling","author":"Link","year":"2021"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1285","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1555","article-title":"Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB","volume":"14","author":"Jiang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189324_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112968","article-title":"Pharmacological and biochemical insights into lead-induced hepatotoxicity: pathway interplay and the protective effects of arbutin via the oral and intraperitoneal routes in silico and in vivo","volume":"142","author":"Elhemiely","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb1295","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23765","article-title":"The potential diagnosis role of TP53 mutation in advanced bladder cancer: a meta-analysis","volume":"35","author":"Liao","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbcan.2025.189324_bb1300","series-title":"The Molecular Clockwork of Mammalian Cells. Seminars in Cell & Developmental Biology","author":"Jonathan","year":"2022"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb1305","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/acs.jnatprod.0c01276","article-title":"Withanolide derivative 2, 3-dihydro-3\u03b2-methoxy withaferin-a modulates the circadian clock via interaction with RAR-related orphan receptor \u03b1 (RORa)","volume":"84","author":"Tomita","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189324_bb1310","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/cancers16234112","article-title":"The circadian rhythm of intracellular Protoporphyrin IX accumulation through Heme synthesis pathway in bladder urothelial cancer cells exposed to 5-Aminolevulinic acid","volume":"16","author":"Nishimura","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189324_bb1315","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/jcp.30759","article-title":"NF-\u03baB as a regulator of cancer metastasis and therapy response: a focus on epithelial\u2013mesenchymal transition","volume":"237","author":"Mirzaei","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103407","article-title":"Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer","volume":"77","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/CMAR.S411168","article-title":"Wnt\/\u03b2-catenin signaling pathway in the development and progression of colorectal cancer","author":"He","year":"2023","journal-title":"Cancer Manag. Res."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189324_bb1330","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.3390\/ijms232315257","article-title":"RNA-interference-mediated miR-122-based gene regulation in colon cancer, a structural in silico analysis","volume":"23","author":"Ganesan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189324_bb1335","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/biomedicines10061357","article-title":"Rac1 as a target to treat dysfunctions and cancer of the bladder","volume":"10","author":"Sauzeau","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb1340","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.gendis.2021.12.025","article-title":"Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer","volume":"9","author":"Das","year":"2022","journal-title":"Genes Diseas."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1345","article-title":"Hypoxia-induced autophagy enhances cisplatin resistance in human bladder cancer cells by targeting hypoxia-inducible factor-1\u03b1","volume":"2021","author":"Mao","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbcan.2025.189324_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118513","article-title":"PI3K\/AKT\/mTOR signaling in gastric cancer: epigenetics and beyond","volume":"262","author":"Fattahi","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189324_bb1355","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2290033","article-title":"Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1","volume":"25","author":"Liu","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189324_bb1360","article-title":"Adenomatous polyposis coli (APC) promoter gene methylation in urine-derived DNA: a non-invasive biomarker for early bladder cancer detection and tumor aggressiveness","volume":"16","author":"Aqerrout","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbcan.2025.189324_bb1365","doi-asserted-by":"crossref","first-page":"102056","DOI":"10.1016\/j.genrep.2024.102056","article-title":"The impact of hydrogen sulfide on mesenchymal stem cells in rats suffering from liver fibrosis via suppression of TGF-\u03b2 signaling","volume":"37","author":"Ellakwa","year":"2024","journal-title":"Gene Rep."},{"key":"10.1016\/j.bbcan.2025.189324_bb1370","first-page":"14","article-title":"Hepatitis B virus X protein and TGF-\u03b2: partners in the carcinogenic journey of hepatocellular carcinoma","author":"Yan","year":"2024","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189324_bb1375","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1080\/15384101.2021.1929677","article-title":"miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3\/SNAIL axis","volume":"20","author":"Wang","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2025.189324_bb1380","series-title":"Notch Interaction with Glycogen Synthase Kinase-3\u03b2 in Neurodegenerative Disease","author":"Traub","year":"2024"},{"key":"10.1016\/j.bbcan.2025.189324_bb1385","article-title":"The role of Notch, Hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies","volume":"9","author":"Kumar","year":"2021","journal-title":"Front. Cell Developm. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189324_bb1390","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/cas.14878","article-title":"Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer","volume":"112","author":"Schulz","year":"2021","journal-title":"Cancer Sci."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189324_bb1395","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2174\/1381612826666200131100630","article-title":"Wnt\/beta-catenin and PI3K\/Akt\/mTOR signaling pathways in glioblastoma: two main targets for drug design: a review","volume":"26","author":"Shahcheraghi","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb1400","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/tox.23354","article-title":"Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3\u03b2 activation","volume":"36","author":"Zhang","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189324_bb1405","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.21873\/anticanres.15432","article-title":"Flaccidoxide induces apoptosis through down-regulation of PI3K\/AKT\/mTOR\/p70S6K signaling in human bladder cancer cells","volume":"41","author":"Wong","year":"2021","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189324_bb1410","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/ijms23031672","article-title":"Propolin G-suppressed epithelial-to-mesenchymal transition in triple-negative breast cancer cells via glycogen synthase kinase 3\u03b2-mediated Snail and HDAC6-regulated vimentin degradation","volume":"23","author":"Pai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189324_bb1415","series-title":"Investigating the Role of Sin3A in Embryonic Stem Cells, during Early Development and in HCT-116 Cells","author":"Lee","year":"2024"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb1420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/pin.70002","article-title":"Evaluation of NANOG\/HDAC1 expression in predicting outcomes of BCG therapy in non-muscle invasive bladder cancer","volume":"75","author":"Yamashita","year":"2025","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbcan.2025.189324_bb1425","article-title":"Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer","volume":"106523","author":"Abbas","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2025.189324_bb1430","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1007\/s11033-020-05744-5","article-title":"Cellular retinol binding protein 1 transfection reduces proliferation and AKT-related gene expression in H460 non-small lung cancer cells","volume":"47","author":"Ferlosio","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbcan.2025.189324_bb1435","series-title":"Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma","first-page":"149","article-title":"Role of transcription factors in hepatocellular carcinoma","volume":"Vol. 2","author":"Shinde","year":"2022"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189324_bb1440","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312855121","article-title":"Tumor\u2013neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression","volume":"121","author":"Jing","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189324_bb1445","article-title":"Accumulation of microtubule-associated protein tau promotes hepatocellular carcinogenesis through inhibiting autophagosome-lysosome fusion","volume":"480","author":"Liu","year":"2024","journal-title":"Mol. Cell. Biochem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:23:59Z","timestamp":1778214239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":289,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0304419X25000666"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189324","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The duality of GSK-3\u03b2 in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189324"}}